Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Recalls With Potential For Serious Health Risks Will Identify Points Of Sale

Oct 08 2018

• By Malcolm Spicer

Magnifying glass-FDA_418713547_1200.jpg

Related Content

Injunction Ends Spiked Supplement Marketers' Attempt To Deceive FDA

Aug 31 2018

Salmonella In Kratom, Like Use Of The Herb, Exceeds FDA Expectations

Jul 02 2018

Additional Topics

United States Dietary Supplements Regulation FDA Manufacturing Advertising, Marketing & Sales Business Strategies Commercial Compliance Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.